Status:
COMPLETED
Nonopioid Analgesia After Arthroscopic Meniscus Surgery
Lead Sponsor:
Henry Ford Health System
Conditions:
Meniscus Disorder
Narcotic Use
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
This is a randomized, single blinded, standard of care controlled clinical trial. This project aims to compare postoperative pain control in patients in two treatment arms of arthroscopic meniscus sur...
Detailed Description
Study Design: This is a randomized, single blinded, standard of care-controlled clinical trial. All adult patients over eighteen desiring arthroscopic meniscus surgery will be eligible. Nonnarcotic po...
Eligibility Criteria
Inclusion
- All adult patients over age 18 scheduled for arthroscopic meniscus repair or partial menisectomy
Exclusion
- Patients with a medical history of known allergies or intolerance to allergies or intolerance to Celebrex, Tylenol, Neurontin, dexamethasone, tramadol, substantial alcohol or drug abuse, and pregnancy, history of narcotics within 6 months of surgery, renal impairment, peptic ulcer disease, GI bleeding.
Key Trial Info
Start Date :
January 22 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 20 2021
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT03820193
Start Date
January 22 2019
End Date
January 20 2021
Last Update
December 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Henry Ford Health System
Detroit, Michigan, United States, 48202